Undervalued Drug Manufacturer Stocks on NAS July 2024

July 07, 2024

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
EVO Evotec 5.30 9.32 75.82 79215 1879 0.00 0.0
TKNO Alpha Teknova 1.20 2.08 73.27 55650 49 0.00 0.0
EVOK Evoke Pharma 0.54 0.89 65.61 31790 5 0.00 0.0
RDHL Redhill Biopharma 0.36 0.59 65.00 267687 2 0.00 0.1
OGI OrganiGram Holdings 1.58 2.46 54.96 622054 144 0.00 0.0
TLRY Tilray Brands 1.73 2.62 51.70 12038537 1305 0.00 0.0
DRRX Durect 1.31 1.94 48.34 105815 40 0.00 0.0
ASRT Assertio Holdings 1.44 1.88 30.50 1579083 137 0.00 0.0
IRWD Ironwood Pharmaceuticals 6.49 8.28 27.57 2755178 1023 0.00 0.0
ORGO Organogenesis Hldgs 2.78 3.50 25.75 856403 367 0.00 69.5
All data provided as at market close July 04, 2024.

Company Details

Evotec

EVO:NAS

Close Price

5.30

Our Valuation

9.32

% Difference

75.82

Market Cap ($M)

1879

P/E Ratio

0.0

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health.

Access the stockcalc valuation


Alpha Teknova

TKNO:NAS

Close Price

1.20

Our Valuation

2.08

% Difference

73.27

Market Cap ($M)

49

P/E Ratio

0.0

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Access the stockcalc valuation


Evoke Pharma

EVOK:NAS

Close Price

0.54

Our Valuation

0.89

% Difference

65.61

Market Cap ($M)

5

P/E Ratio

0.0

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Access the stockcalc valuation


Redhill Biopharma

RDHL:NAS

Close Price

0.36

Our Valuation

0.59

% Difference

65.00

Market Cap ($M)

2

P/E Ratio

0.1

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin).

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

OrganiGram Holdings

OGI:NAS

Close Price

1.58

Our Valuation

2.46

% Difference

54.96

Market Cap ($M)

144

P/E Ratio

0.0

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Access the stockcalc valuation


Tilray Brands

TLRY:NAS

Close Price

1.73

Our Valuation

2.62

% Difference

51.70

Market Cap ($M)

1305

P/E Ratio

0.0

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Access the stockcalc valuation


Durect

DRRX:NAS

Close Price

1.31

Our Valuation

1.94

% Difference

48.34

Market Cap ($M)

40

P/E Ratio

0.0

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Access the stockcalc valuation


Assertio Holdings

ASRT:NAS

Close Price

1.44

Our Valuation

1.88

% Difference

30.50

Market Cap ($M)

137

P/E Ratio

0.0

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Access the stockcalc valuation


Ironwood Pharmaceuticals

IRWD:NAS

Close Price

6.49

Our Valuation

8.28

% Difference

27.57

Market Cap ($M)

1023

P/E Ratio

0.0

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases.

Access the stockcalc valuation


Organogenesis Hldgs

ORGO:NAS

Close Price

2.78

Our Valuation

3.50

% Difference

25.75

Market Cap ($M)

367

P/E Ratio

69.5

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Evotec and Alpha Teknova are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-july-2024
Evotec $EVO and Alpha Teknova $TKNO are the most undervalued Drug Manufacturers stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-july-2024
Evotec and Alpha Teknova are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-july-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.